Jan 10 (Reuters)-
Cosmos Pharmaceutical Corp.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Nov 30, 2019 Nov 30, 2018 May 31, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 325.27 298.37 658.50
(+9.0 pct) (+10.2 pct) (+7.7 pct)
Operating 11.97 12.33 24.80
(-2.9 pct) (+19.8 pct) (+0.1 pct)
Recurring 13.11 13.50 27.30
(-2.9 pct) (+16.5 pct) (+0.0 pct)
Net 8.77 9.01 19.19
(-2.6 pct) (+15.7 pct) (+0.0 pct)
EPS 443.00 yen 454.83 yen 969.21 yen
Ann Div 100.00 yen 100.00 yen
-Q2 div 50.00 yen 45.00 yen
-Q4 div 55.00 yen 50.00 yen
NOTE - Cosmos Pharmaceutical Corp..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T